Market Tracker

10/24 6:05pm ET

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.73
Data as of Oct 24
 -0.15 / -7.98%
Today’s Change
1.57
Today|||52-Week Range
5.35
-40.34%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close1.88
Today’s open1.88
Day’s range1.65 - 1.88
Volume13,161
Average volume (3 months)36,913
Market cap$20.5M
Dividend yield--
Data as of 3:57pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-83.83%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+153.36%
P/E ratio--
Price/Sales13.65
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
TPITianyin Pharmaceutic...+0.02+3.85%
CYANCyanotech Corp0.000.00%
ATOSAtossa Genetics Inc-0.00-0.14%
EVOKEvoke Pharma Inc+0.04+0.84%
Data as of 3:59pm ET, 10/24/2014

Financials

Last reporting dateSeptember 8, 2008
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$2.4M
Annual profit (last year)-$2.5M
Net profit margin-104.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Herzliya, --

Forecasts